DELFI uses AI, machine learning and whole genome sequencing to sensitively detect unique patterns of DNA fragmentation in the blood of patients with cancer.
Looking for a particular DELFI Diagnostics employee's phone or email?
The DELFI Diagnostics annual revenue was $6.2 million in 2026.
Susan Tousi is the CEO of DELFI Diagnostics.
116 people are employed at DELFI Diagnostics.
DELFI Diagnostics is based in Palo Alto, California.
The NAICS codes for DELFI Diagnostics are [62, 6215, 621, 62151].
The SIC codes for DELFI Diagnostics are [807, 80].